TFF3 and cancer: To further substantiate the synergistic effects of AMPC and c-METis identified through high-throughput screening of the anti-cancer compound library, the pharmacological inhibition of TFF3 by AMPC in combination with three c-METis was further evaluated in MDA-MB-361 and BT474 cells by total cell number assay (Fig. 5A).